ABSTRACT
Background The Annals of Internal Medicine (AIM) has adopted a policy encouraging data-sharing since 2007.
Objective To explore the impact of the AIM data-sharing policy for randomized controlled trials (RCTs) in terms of output from data-sharing (i.e. publications re-using the data).
Design Retrospective study.
Setting AIM.
Participants RCTs published in the AIM between 2007 and 2017 were retrieved on PubMed. Publications where the data had been re-used were identified on Web of Science. Searches were performed by two independent reviewers.
Interventions Intention to share data (or not) expressed in a data-sharing statement.
Measurements The primary outcome was any published re-use of the data (i.e. re-analysis, secondary analysis, or meta-analysis of individual participant data [MIPD]), where the first, last and corresponding authors were not among the authors of the RCT. Components of the primary outcome and analyses without any author restriction were secondary outcomes. Analyses used Cox (primary analysis) models adjusting for RCT characteristics.
Results 185 RCTs were identified. 106 (57%) mentioned willingness to share data and 79 (43%) did not. 208 secondary analyses, 67 MIPD and no re-analyses were identified. No significant association was found between intent to share and re-use where the first, last and corresponding authors were not among the authors of the primary RCT (adjusted hazard ratio = 1.04 [0.47-2.30]). Secondary outcomes also showed no association between intent to share and re-use.
Limitations Possibility of residual confounding and limited power.
Conclusion Over ten years, RCTs published in AIM expressing an intention to share data were not associated with more extensive re-use of the data.
Registration https://osf.io/8pj5e/
Funding Source Grants from the Fondation pour la Recherche Médicale, Région Bretagne, and French National Research Agency.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
Funding Statement
This work was supported by the Fondation pour la Recherche M?cale, grant number 6616 to Claude Pellen, and a R?on Bretagne Boost ERC grant (18HC432-01N). Work by FN on data-sharing is supported by a grant from the French National Research Agency - ANR (Reproducibility in Therapeutic Research / ReITheR: ANR-17-CE36-0010-01).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not Applicable.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Study protocol, statistical code, data set and web-appendixes: available on the OSF platform